PodParley PodParley
PodParley
Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - report from ASH2024 episode artwork

EPISODE · Dec 20, 2024 · 10 MIN

Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - report from ASH2024

from Medical Digest & Congress Report · host Medical Congress News

Martin Hutchings, MD, PhD discusses the role of CAR T-Cell therapy and bispecific antibodies in the management of lymphoma at the 2024 ASH Annual Meeting. Video: https://medicaldigest.org/scientific-contents/interview:addressing-current-questions-and-controversies-regarding-role-car-t-cell-therapy-and-bispecific-antibodies-management-lymphoma

Episode metadata supplied by the publisher feed · Published Dec 20, 2024

Embed this episode

Ready to play

Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma - report from ASH2024

0:00 10:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 10 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 20, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!